POZEN Reaches New 52-Week High (POZN)

NEW YORK ( TheStreet) -- POZEN (Nasdaq: POZN) hit a new 52-week high Tuesday as it is currently trading at $7.76, above its previous 52-week high of $7.75 with 8,038 shares traded as of 9:30 a.m. ET. Average volume has been 336,500 shares over the past 30 days.

POZEN has a market cap of $202 million and is part of the health care sector and drugs industry. Shares are up 92.7% year to date as of the close of trading on Monday.

POZEN Inc., a pharmaceutical company, develops products for the treatment of acute and chronic pain, and other pain-related conditions in the United States. The company has a P/E ratio of 5.1, above the average drugs industry P/E ratio of 4.8 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates POZEN as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. You can view the full POZEN Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.